ICOD_Project

We will wait with our ICOD coordinator Rafael De La Torre tomorrow at 18,00 for the T21RS | Webinar 27 | The European ICOD project: new evidence for DS families!! Thank you #T21RS Education Committee,#IMIM #hadea See you on ZOOM us02web.zoom.us/w/86977010569?…

A great honor to participate as Italian Deputy for IHI network to the meeting at our Senate of the Republic about “Science for all" !! A Great Occasion to discuss also about dissemination activities for DS families in our European ICOD Project A great Thanks to #Esperia #HaDEA

On #WorldDownSyndromeDay, discover how EU-funded research is contributing to enhancing our understanding of Down syndrome and improving the cognitive development, autonomy and quality of life of people living with this condition. 🔗hadea.ec.europa.eu/news/world-dow… #H2020

#WorldDownSyndromeDay AEF0217 : The first patient first visits in our Phase 2B clinical trial were completed in December 2025, marking the successful operational launch of the study. Today, screening and recruitment are actively underway across participating centres in Europe.

🧬 International Rare Disease Day – Feb 28 At Aelis Farma, we are convinced that therapeutic innovation in rare diseases also requires exploring new biological mechanisms.

“Therapeutic Perspectives for Intellectual Disability in Down Syndrome”. Workshop promosso dall’AIPD – Associazione Italiana Persone con Sindrome di Down, sezione di Potenza, in collaborazione con la Task Force Italiana sulla Trisomia 21.

Happy to share our third publication of @ICOD_Project where we demonstrate that low IL-18 free levels contribute with high TNF-alfa and reduced TGF-β1 plasma levels to cognitive decline in Down syndrome and also suggest news target to treat cognitive decline in DS!! #Hadea #IMIM

A great Advance for Our ICOD Project! Aelis Farma receives a positive opinion from EMA Pediatric Committee on the Pediatric Investigation Plan for AEF0217 in Down syndrome! @EU_HaDEA @EU_Commission @AelisFarma #IMIM #Icodproject #DS news.newcontact.eu/images/clients…

Great news and a great advance for DS families!! Ready to start with the Phase 2B study !! Thanks to #EuropeanCommission #Icodproject #aelisfarma #Hadea #EMA #AIFA #IMIM #OasiResearchInstitute #UniCT

👉 𝗔 𝗺𝗮𝗷𝗼𝗿 𝘀𝘁𝗲𝗽 𝘁𝗼𝘄𝗮𝗿𝗱𝘀 𝗮 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝘃𝗲 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀 𝗮𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗗𝗼𝘄𝗻 𝘀𝘆𝗻𝗱𝗿𝗼𝗺𝗲. s3.eu-central-1.amazonaws.com/aelis.investor…

Dr Pier Vincenzo PIAZZA was interviewed by L’Esprit Curieux 🎙️ Watch the full interview here: youtube.com/watch?v=1S-7Kk…

A Great Thanks to the Italian DS Task Force and this Round Table where we have had the opportunity to discuss with DS associations about Innovative drugs and Autonomy fir DS!! #Icodproject #DSTaskForce #IMIM #aelis #EuropeanUnion

@AdrianoAguzzi A translation would help....for non italians. ..

Buon ferragosto ! #aipd #soloconaipd #aipd #aipd_nazionale #presidentenazionaleaipd #sindromedidown #sindromedown #sindromededown #sindrome #down #downsyndrome #associazioneitalianapersonedown

Now in @NatureNeuro! Thanks to a big collaborative effort, we have created a new tool to enhance mitochondrial function using DREADDS. This results in increased oxygen consumption and rescues cognitive deficits in cannabinoid- treated mice, and in Alzheimer and dementia models!

@MarsicanoLab @NatureNeuro Great work!!

A strong immune system may be key to preventing Alzheimer’s disease. People with higher titers of anti-viral antibodies were less likely to have dementia. @NIHAging ow.ly/lM6x50WehAH

Seminari #Neurociències @hospitaldelmar - @HMar_research 📅 Dijous 19 de juny 🕗 08:00 h 📍Sala Josep Marull 🗣️ Dr. Eduard Vieta @hospitalclinic @idibaps 🎯 Actualització i novetats en trastorn bipolar 👉researchmar.net/agenda/963

Today is #EuropeDay. We believe that the European Union needs to do much more for disability rights. But we have to acknowledge the key advances it was responsible for. On 9 May, read '9 things the European Union does for persons with disabilities': edf-feph.org/9-things-the-e…